Sweta Agrawal: Expanding Access to Life-Changing PNH Therapy in Nepal
Sweta Agrawal, Program Coordinator of Nepal at The Max Foundation, shared The Max Foundation’s post on LinkedIn:
“I am honoured to work with Dr. Lama and learn so much from him.
I have met and interacted with PNH patients at Patan Hospital and the results are just amazing.
They share their experiences and each one is doing great on medication.”
The Max Foundation shared a post on LinkedIn:
“For physicians like Dr. Mipsang Lama in Nepal, there was a time when the rare and devastating blood disorder of Paroxysmal Nocturnal Hemoglobinuria (PNH) could be identified but not truly treated.
Care meant repeated transfusions, temporary stabilization, and watching patients live with constant uncertainty.
Then, thanks to our partnership with Novartis Global Health and the International PNH Interest Group, access to treatment and training changed that!
Within weeks, patients began regaining strength.
Conversations shifted from survival to possibility.
For Dr. Lama, it was more than a clinical change.
It was the ability to finally offer hope alongside care.
He shared: ‘To those working in global health and rare disease access, your work has a deeply human impact.
PNH may be rare, but the suffering it causes is real and significant.
Today, for the first time, we can say with confidence that ‘it is treatable.”
You can read more about the impact access is having in Nepal.”
Stay updated with Hemostasis Today.
-
Aug 24, 2026, 18:13Chokri Ben Lamine: Ruxolitinib – Comprehensive Clinical Reference
-
Aug 24, 2026, 18:10Yazan Abou-Ismail: ClotCast Episode 8 – What Are Platelets?
-
Aug 24, 2026, 17:11Kristin Neves: Which Hematologic Parameters Guide Your PV Treatment Decisions?
-
Aug 24, 2026, 17:00Should Hormone Therapy Automatically Stop After a Thrombosis? – Thrombosis Canada
-
Aug 24, 2026, 16:52Davide Capodanno: 10 Trials to Watch at the ESC Hot Lines
-
Aug 24, 2026, 16:48Mohd Ashhad: The Science Behind a Safe Transfusion
-
Aug 24, 2026, 16:38PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
-
Aug 24, 2026, 16:36Alejandro González Veliz։ Does ACC/AHA Lesion Complexity Still Matter?
-
Aug 24, 2026, 16:21Kamlesh Darji: Paraneoplastic Syndromes – Tumor with or without Mediator